These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31272105)

  • 1. Loss of FLCN inhibits canonical WNT signaling via TFE3.
    Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
    Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birt-Hogg-Dube syndrome is a novel ciliopathy.
    Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
    Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.
    Kennedy JC; Khabibullin D; Boku Y; Shi W; Henske EP
    Semin Respir Crit Care Med; 2020 Apr; 41(2):247-255. PubMed ID: 32279295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome.
    Chu L; Luo Y; Chen H; Miao Q; Wang L; Moats R; Wang T; Kennedy JC; Henske EP; Shi W
    Thorax; 2020 Jun; 75(6):486-493. PubMed ID: 32238524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.
    Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z
    Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
    Schmidt LS
    Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
    Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
    PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome.
    Hoshika Y; Takahashi F; Togo S; Hashimoto M; Nara T; Kobayashi T; Nurwidya F; Kataoka H; Kurihara M; Kobayashi E; Ebana H; Kikkawa M; Ando K; Nishino K; Hino O; Takahashi K; Seyama K
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27905298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
    Tee AR; Pause A
    Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
    Di Malta C; Zampelli A; Granieri L; Vilardo C; De Cegli R; Cinque L; Nusco E; Pece S; Tosoni D; Sanguedolce F; Sorrentino NC; Merino MJ; Nielsen D; Srinivasan R; Ball MW; Ricketts CJ; Vocke CD; Lang M; Karim B; Lanfrancone L; Schmidt LS; Linehan WM; Ballabio A
    EMBO Mol Med; 2023 May; 15(5):e16877. PubMed ID: 36987696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
    Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
    Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
    Isono Y; Furuya M; Kuwahara T; Sano D; Suzuki K; Jikuya R; Mitome T; Otake S; Kawahara T; Ito Y; Muraoka K; Nakaigawa N; Kimura Y; Baba M; Nagahama K; Takahata H; Saito I; Schmidt LS; Linehan WM; Kodama T; Yao M; Oridate N; Hasumi H
    Biochem Biophys Res Commun; 2020 Feb; 522(4):931-938. PubMed ID: 31806376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome.
    Napolitano G; Di Malta C; Esposito A; de Araujo MEG; Pece S; Bertalot G; Matarese M; Benedetti V; Zampelli A; Stasyk T; Siciliano D; Venuta A; Cesana M; Vilardo C; Nusco E; Monfregola J; Calcagnì A; Di Fiore PP; Huber LA; Ballabio A
    Nature; 2020 Sep; 585(7826):597-602. PubMed ID: 32612235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
    Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
    Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
    Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
    BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
    Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
    PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.
    Goncharova EA; Goncharov DA; James ML; Atochina-Vasserman EN; Stepanova V; Hong SB; Li H; Gonzales L; Baba M; Linehan WM; Gow AJ; Margulies S; Guttentag S; Schmidt LS; Krymskaya VP
    Cell Rep; 2014 Apr; 7(2):412-423. PubMed ID: 24726356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines.
    Glykofridis IE; Henneman AA; Balk JA; Goeij-de Haas R; Westland D; Piersma SR; Knol JC; Pham TV; Boekhout M; Zwartkruis FJT; Wolthuis RMF; Jimenez CR
    Mol Cell Proteomics; 2022 Sep; 21(9):100263. PubMed ID: 35863698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.